Ola Mashni
5PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 24, 2025
Characteristics of adverse drug reactions resulting in modifications of antineoplastic therapy plan in patients with breast cancer at a comprehensive cancer center.Saba Marji, Raghad Tawalbeh, Amal AlJammal
|Oct 29, 2024
Incidence, characteristics, and clinical impact of serious adverse events in patients with breast cancer receiving antineoplastic treatment in the ambulatory setting.Zahieh AbuAloush, Wedad Awad, Ola Mashni
|Jan 17, 2022
Retrospective study evaluating immune-related adverse events in cancer patients treated with pembrolizumab.Ola K Mashni, Dima W Baba, Aseel N Mahmoud
|Mar 24, 2021
Impact of Clinical Pharmacy Services on Patient Management in the Chemotherapy Infusion Clinics: A 5-Year Study at a Comprehensive Cancer Center.Ola K Mashni, Lama H Nazer, Haya Z Khalil
|Jul 02, 2019
Etoposide dosage adjustment in two patients with neuroendocrine tumors and severe liver impairment.Ola Mashni, Khlood Qasem, Aseel Abu Sara
Pageof 1
